PAR AND SPECTRUM JOIN TO DISTRIBUTE GENERICS

Published Online: Saturday, April 1, 2006
Follow Pharmacy_Times:

Spectrum Pharmaceuticals will begin distribution of generic drugs produced by Par Pharmaceutical under a new strategic alliance agreed to by the 2 companies. Under the agreement, Par will make an unspecified equity investment in Spectrum, and Spectrum will receive payments based on achievement of specified regulatory approvals that company officials believe to be worth over $10 million. Par will also provide financial and legal support for the ongoing patent challenge for sumatriptan injection—a migraine treatment originally developed by GlaxoSmithKline—and both companies will share profits resulting from the sale of the generic products.




Related Articles
No Result Found
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$
VSEO N/A